GD2T cells as a platform for single-dose and long-term delivery of biologics

Journal:

Nature Communications

Published:

2025-08-29

DOI:

10.1038/s41467-025-63427-w

Affiliations:

6

Authors:

3

Go to article

Institutions	Authors	Share
Tsinghua University, China	1.500000	0.50
State Key Laboratory of Molecular Oncology, China	0.500000	0.17
SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, China	0.500000	0.17
Tsinghua - PKU Joint Center for Life Sciences (CLS), China	0.500000	0.17

Interested in Oncology and Carcinogenesis?